Institutional Manager · CIK 0001475373
SECTOR GAMMA AS
OSLO, Q8 · File #028-13612
Latest AUM
$438.7M
Positions
36
Top-10 Concentration
55.7%
Filings
9
Portfolio Value Over Time
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
2025-09
2025-12
Biggest QoQ Changes
Ranked by conviction flow (share change × current price) so mark-to-market moves don't dominate. Price effect column shows how much of the $ change was just the stock moving.
| Action | Issuer | Ticker / CUSIP | Δ Shares | Flow ($) | Price Effect |
|---|---|---|---|---|---|
| REDUCE | PFIZER INC | PFE | -392,547 | -$9.8M | -$726,210 |
| ADD | BRISTOL-MYERS SQUIBB CO | CELG-RI | +164,688 | +$8.9M | +$5.1M |
| EXITED | BAXTER INTL INC | 071813109 | -381,551 | -$8.7M | $0 |
| ADD | ELEVANCE HEALTH INC FORMERLY | ELV | +22,943 | +$8.0M | +$263,411 |
| REDUCE | IONIS PHARMACEUTICALS INC | IONS | -85,986 | -$6.8M | +$3.7M |
| EXITED | VIATRIS INC | 92556V106 | -668,851 | -$6.6M | $0 |
| EXITED | HUMANA INC | 444859102 | -23,942 | -$6.2M | $0 |
| EXITED | ELANCO ANIMAL HEALTH INC | 28414H103 | -307,271 | -$6.2M | $0 |
| NEW | REGENERON PHARMACEUTICALS | REGN | +7,165 | +$5.5M | $0 |
| NEW | CRINETICS PHARMACEUTICALS IN | CRNX | +115,000 | +$5.4M | $0 |
Sector Allocation
Filing History
- 13F HOLDINGS REPORTQ/E Dec 202536 pos · $438.7M
- 13F HOLDINGS REPORTQ/E Sep 202541 pos · $403.3M
- 13F HOLDINGS REPORTQ/E Jun 202538 pos · $305.9M
- 13F HOLDINGS REPORTQ/E Mar 202533 pos · $312.2M
- 13F HOLDINGS REPORTQ/E Dec 202430 pos · $290.9M
- 13F HOLDINGS REPORTQ/E Sep 202429 pos · $329.6M
- 13F HOLDINGS REPORTQ/E Jun 202428 pos · $267.7M
- 13F HOLDINGS REPORTQ/E Mar 202428 pos · $354.8M
- 13F HOLDINGS REPORTQ/E Dec 202328 pos · $391.3M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 745,955 | $40.2M | 9.17% |
| 2 | MERCK & CO INC | MRK | 363,651 | $38.3M | 8.73% |
| 3 | MEDTRONIC PLC | MDT | 269,644 | $25.9M | 5.90% |
| 4 | BECTON DICKINSON & CO | BDX | 132,376 | $25.7M | 5.86% |
| 5 | GILEAD SCIENCES INC | GILD | 176,414 | $21.7M | 4.94% |
| 6 | INCYTE CORP | INCY | 218,783 | $21.6M | 4.93% |
| 7 | PFIZER INC | PFE | 859,539 | $21.4M | 4.88% |
| 8 | AMGEN INC | AMGN | 60,956 | $20.0M | 4.55% |
| 9 | BIOGEN INC | BIIB | 85,475 | $15.0M | 3.43% |
| 10 | IONIS PHARMACEUTICALS INC | IONS | 184,977 | $14.6M | 3.34% |
| 11 | CVS HEALTH CORP | CVS | 177,599 | $14.1M | 3.21% |
| 12 | CARDINAL HEALTH INC | CAH | 61,946 | $12.7M | 2.90% |
| 13 | THERMO FISHER SCIENTIFIC INC | TMO | 21,688 | $12.6M | 2.86% |
| 14 | BRUKER CORP | BRKRP | 254,697 | $12.0M | 2.73% |
| 15 | ZIMMER BIOMET HOLDINGS INC | ZBH | 132,478 | $11.9M | 2.72% |
| 16 | BIOMARIN PHARMACEUTICAL INC | BMRN | 198,505 | $11.8M | 2.69% |
| 17 | ELEVANCE HEALTH INC FORMERLY | ELV | 32,546 | $11.4M | 2.60% |
| 18 | CENTENE CORP DEL | CNC | 258,109 | $10.6M | 2.42% |
| 19 | GE HEALTHCARE TECHNOLOGIES I | GEHC | 114,390 | $9.4M | 2.14% |
| 20 | EDWARDS LIFESCIENCES CORP | EW | 96,402 | $8.2M | 1.87% |